Hyperglycaemia alters the endothelium-dependent relaxation of canine coronary arteries

被引:0
作者
Kocsis, E
Pacher, P
Pósa, I
Nieszner, E
Pogátsa, G
Koltai, MZ
机构
[1] Gyorgy Gottsegen Natl Inst Cardiol, Res Dept, H-1096 Budapest, Hungary
[2] Semmelweis Univ, Dept Pharmacol, H-1085 Budapest, Hungary
[3] Haynal Imre Univ Med Sci, Ctr Cardiovasc, Budapest, Hungary
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 2000年 / 169卷 / 03期
关键词
acetylcholine; coronary artery; dog; endothelium; experimental diabetes; hyperglycaemia; in vitro;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of the present study was to investigate the effects of experimental diabetes and hyperglycaemia per se on the endothelium-dependent relaxation of isolated canine coronary arteries and to analyse the possible involvement of the cyclooxygenase pathway in the alterations induced by hyperglycaemia. Rings from the left anterior descending coronary arteries of 18 metabolically healthy, six alloxan-diabetic and six insulin-treated alloxan diabetic dogs were set up for isometric tension recording. Diabetic coronaries as well as healthy vessels subjected to in vitro hyperglycaemia (25.5 mmol L-1 glucose) showed impaired (P < 0.05) relaxation to acetylcholine (3 nmol L-1-10 mu mol L-1) compared with normoglycaemic, i.e. metabolically healthy and insulin-treated diabetic controls, either before or after indomethacin (3 mu mol L-1) administration. The maximal dilation elicited by acetylcholine was further decreased (P < 0.05) by the cyclooxygenase inhibitor in the diabetic coronaries only. Relaxation to sodium nitroprusside did not differ among groups. These results suggest that hyperglycaemia may result in impaired endothelium-dependent dilation of coronary arteries. Diminished relaxation of diabetic coronaries is worsened by the inhibition of the synthesis of vasodilator cyclooxygenase products.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 23 条
[11]   Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM [J].
Lehto, S ;
Ronnemaa, T ;
Haffner, SM ;
Pyorala, K ;
Kallio, V ;
Laakso, M .
DIABETES, 1997, 46 (08) :1354-1359
[12]   Risk factors predicting lower extremity amputations in patients with NIDDM [J].
Lehto, S ;
Pyorala, K ;
Ronnemaa, T ;
Laakso, M .
DIABETES CARE, 1996, 19 (06) :607-612
[13]   GLUCOSE TOXICITY FOR HUMAN-ENDOTHELIAL CELLS IN CULTURE - DELAYED REPLICATION, DISTURBED CELL-CYCLE, AND ACCELERATED DEATH [J].
LORENZI, M ;
CAGLIERO, E ;
TOLEDO, S .
DIABETES, 1985, 34 (07) :621-627
[14]   Impairment of coronary blood flow regulation by endothelium-derived nitric oxide in dogs with alloxan-induced diabetes [J].
Matsunaga, T ;
Okumura, K ;
Ishizaka, H ;
Tsunoda, R ;
Tayama, S ;
Tabuchi, T ;
Yasue, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (01) :60-67
[15]   IMPAIRMENT OF CORONARY VASCULAR RESERVE AND ACH-INDUCED CORONARY VASODILATION IN DIABETIC-PATIENTS WITH ANGIOGRAPHICALLY NORMAL CORONARY-ARTERIES AND NORMAL LEFT-VENTRICULAR SYSTOLIC FUNCTION [J].
NITENBERG, A ;
VALENSI, P ;
SACHS, R ;
DALI, M ;
APTECAR, E ;
ATTALI, JR .
DIABETES, 1993, 42 (07) :1017-1025
[16]   ALTERED ADRENERGIC RESPONSES OF THE CORONARY ARTERIAL BED IN ALLOXAN-DIABETIC DOGS [J].
PALIK, I ;
KOLTAI, MZ ;
WAGNER, M ;
KOLONICS, I ;
POGATSA, G .
EXPERIENTIA, 1982, 38 (08) :934-935
[17]   Diabetes complications: Why is glucose potentially toxic? [J].
Porte, D ;
Schwartz, MW .
SCIENCE, 1996, 272 (5262) :699-700
[18]   Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs - Evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels [J].
Puybasset, L ;
Bea, ML ;
Ghaleh, B ;
Giudicelli, JF ;
Berdeaux, A .
CIRCULATION RESEARCH, 1996, 79 (02) :343-357
[19]  
Rosen Peter, 1996, Diabetes Research and Clinical Practice, V31, pS143
[20]  
TESMAFARIAM B, 1990, J CLIN INVEST, V85, P929